» Articles » PMID: 34386668

Impact of Using Risk-Based Stratification on Referral of Patients With Chronic Kidney Disease From Primary Care to Specialist Care in the United Kingdom

Overview
Journal Kidney Int Rep
Publisher Elsevier
Specialty Nephrology
Date 2021 Aug 13
PMID 34386668
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The externally validated Kidney Failure Risk Equation (KFRE) for predicting risk of end-stage renal disease (ESRD) has been developed, but its potential impact in a population on referrals for patients with chronic kidney disease (CKD) from primary to specialty nephrology care is not known.

Methods: A cross-sectional population-based study of individuals in United Kingdom primary care registered in The Health Improvement Network database was conducted. National Institute of Health and Care Excellence (NICE) 2014 CKD guidelines the 4-variable KFRE set at a >3% risk of ESRD at 5 years were applied to patients identified with CKD stage 3-5 between January 1, 2016, and March 31, 2017.

Results: In all, 39,476 (36.6%) of 107,962 adults with CKD stage 3-5 had a urine albumin:creatinine ratio (ACR) available and entered into the primary analysis. Of that, 7566 (19.2%) patients fulfilled NICE criteria for referral, 2386 (31.5%) of whom had a ≤3% 5-year risk of ESRD. Also 8663 (21.9%) patients had a >3% 5-year risk of ESRD, 3483 (40.2%) of whom did not fulfill NICE criteria; this represents 8.8% of the primary population. By using the KFRE threshold rather than NICE criteria for referral, 5869 patients (14.9% of the primary analysis population) would have been reallocated between primary and specialist care. Imputational analysis was used for missing ACR measurements and showed similar results.

Conclusions: A risk-based referral approach would lead to a substantial reallocation of patients between primary care and specialist nephrology care with only a small increase in numbers eligible, ensuring those at higher risk of progression are identified.

Citing Articles

Recalibrating the kidney failure risk equation for a Mediterranean European population: reducing age and sex inequality.

Bundo-Luque D, Cunillera-Puertolas O, Cobo-Guerrero S, Romano J, Arbiol-Roca A, Dominguez-Alonso J Front Med (Lausanne). 2025; 11:1497780.

PMID: 39944820 PMC: 11813909. DOI: 10.3389/fmed.2024.1497780.


When impact trials are not feasible: alternatives to study the impact of prediction models on clinical practice.

Janse R, Stel V, Jager K, Tripepi G, Zoccali C, Dekker F Nephrol Dial Transplant. 2024; 40(1):27-33.

PMID: 39020254 PMC: 11852334. DOI: 10.1093/ndt/gfae170.


Primary and specialist care interaction and referral patterns for individuals with chronic kidney disease: a narrative review.

Mutatiri C, Ratsch A, McGrail M, Venuthurupalli S, Chennakesavan S BMC Nephrol. 2024; 25(1):149.

PMID: 38689219 PMC: 11061991. DOI: 10.1186/s12882-024-03585-z.


Clinical Decision Support Tools in the Electronic Medical Record.

Alexiuk M, Elgubtan H, Tangri N Kidney Int Rep. 2024; 9(1):29-38.

PMID: 38312784 PMC: 10831391. DOI: 10.1016/j.ekir.2023.10.019.


Implementation of the Kidney Failure Risk Equation in a United States Nephrology Clinic.

Patel D, Churilla B, Thiessen-Philbrook H, Sang Y, Grams M, Parikh C Kidney Int Rep. 2023; 8(12):2665-2676.

PMID: 38106577 PMC: 10719573. DOI: 10.1016/j.ekir.2023.09.001.


References
1.
Hingwala J, Wojciechowski P, Hiebert B, Bueti J, Rigatto C, Komenda P . Risk-Based Triage for Nephrology Referrals Using the Kidney Failure Risk Equation. Can J Kidney Health Dis. 2017; 4:2054358117722782. PMC: 5555495. DOI: 10.1177/2054358117722782. View

2.
Herzog C, Asinger R, Berger A, Charytan D, Diez J, Hart R . Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011; 80(6):572-86. DOI: 10.1038/ki.2011.223. View

3.
Hallan S, Matsushita K, Sang Y, Mahmoodi B, Black C, Ishani A . Age and association of kidney measures with mortality and end-stage renal disease. JAMA. 2012; 308(22):2349-60. PMC: 3936348. DOI: 10.1001/jama.2012.16817. View

4.
Fenton A, Jesky M, Webster R, Stringer S, Yadav P, Chapple I . Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease. PLoS One. 2018; 13(5):e0197043. PMC: 5942781. DOI: 10.1371/journal.pone.0197043. View

5.
Tangri N, Stevens L, Griffith J, Tighiouart H, Djurdjev O, Naimark D . A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011; 305(15):1553-9. DOI: 10.1001/jama.2011.451. View